Expert Highlights Genetic Testing, Immunotherapy in Endometrial Cancer – OncLive
OncLive |
Expert Highlights Genetic Testing, Immunotherapy in Endometrial Cancer
OncLive Mismatch repair deficiency (dMMR) and microsatellite instability-high (MSI-H) testing may improve classifications of endometrial cancer and lead to personalized treatment options, according to Martee L. Hensley, MD. If patients' tumors test positive … |
